NO20065763L - Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention - Google Patents

Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention

Info

Publication number
NO20065763L
NO20065763L NO20065763A NO20065763A NO20065763L NO 20065763 L NO20065763 L NO 20065763L NO 20065763 A NO20065763 A NO 20065763A NO 20065763 A NO20065763 A NO 20065763A NO 20065763 L NO20065763 L NO 20065763L
Authority
NO
Norway
Prior art keywords
pharaceutical
progcess
manufacturing
water insoluble
quick release
Prior art date
Application number
NO20065763A
Other languages
English (en)
Inventor
Poul Bertelsen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of NO20065763L publication Critical patent/NO20065763L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det har vist seg at farmasøytiske preparater som inneholder vannløselige legemidler kan fremstilles og formuleres på en make som sikrer hurtig oppløsning i magevæske. Det er en fordel at fremstillingsprosessen tilveiebringer en signifikant forbedret stabilitet, hvilket således resulterer i preparater som kan ha lengre holdbarhet enn konvensjonelt formulerte og fremstilte legemidler.
NO20065763A 2004-06-29 2006-12-14 Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention NO20065763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401021 2004-06-29
PCT/DK2005/000435 WO2006000228A2 (en) 2004-06-29 2005-06-28 Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention

Publications (1)

Publication Number Publication Date
NO20065763L true NO20065763L (no) 2007-01-29

Family

ID=34973654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065763A NO20065763L (no) 2004-06-29 2006-12-14 Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention

Country Status (23)

Country Link
US (2) US20070218128A1 (no)
EP (1) EP1916994B1 (no)
JP (2) JP5438898B2 (no)
KR (1) KR100875299B1 (no)
CN (2) CN101513391B (no)
AU (1) AU2005256321B2 (no)
BR (1) BRPI0508063A (no)
CA (1) CA2572359C (no)
EA (2) EA014443B1 (no)
ES (1) ES2450648T3 (no)
GE (1) GEP20094671B (no)
IL (1) IL180071A0 (no)
MA (1) MA28754B1 (no)
MX (1) MXPA06015131A (no)
NO (1) NO20065763L (no)
NZ (1) NZ552208A (no)
PL (1) PL1916994T3 (no)
SA (2) SA05260191B1 (no)
TN (1) TNSN06434A1 (no)
TW (1) TWI376242B (no)
UA (1) UA93353C2 (no)
WO (1) WO2006000228A2 (no)
ZA (1) ZA200700531B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2450648T3 (es) * 2004-06-29 2014-03-25 Takeda Pharma A/S Fabricación de composiciones farmacéuticas con liberación rápida de fármacos insolubles en agua y composiciones farmacéuticas obtenidas mediante el procedimiento de la invención
WO2009026257A2 (en) * 2007-08-17 2009-02-26 Teva Pharmaceutical Industries Ltd. Methods and compositions for controlling the bioavailability of poorly soluble drugs
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
BE1018279A3 (fr) * 2008-09-09 2010-08-03 Squarepoint Pointcarre Sprl Composition de nimesulide orodispersible.
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
US11135188B2 (en) * 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
CN101693030A (zh) * 2009-10-22 2010-04-14 哈尔滨健迪医药技术有限公司 一种用于外用止痛的药物组合物及其制备方法
UA103955C2 (ru) * 2009-11-05 2013-12-10 Алкем Леборетриз Лтд. Стойкая инъекционная фармацевтическая композиция ацеклофенака и способ ее получения
EP2394641A1 (en) 2010-05-30 2011-12-14 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of lornoxicam
US20130122098A1 (en) * 2011-11-14 2013-05-16 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
CN103565812A (zh) * 2012-08-06 2014-02-12 徐静 一种含氯诺昔康的口服速释止痛制剂的制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
NO2699580T3 (no) 2014-01-24 2018-02-24
BE1021194B1 (nl) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba Paracetamol tabletten
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
CN107929247A (zh) * 2016-10-13 2018-04-20 长春海悦药业股份有限公司 一种布洛肾素那敏片剂组合物及其制备方法
EP3758708A1 (en) * 2018-03-01 2021-01-06 AstraZeneca AB Pharmaceutical compositions comprising (2s)--{(1s)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
CA3201462A1 (en) 2020-11-13 2022-05-19 Bayer Healthcare Llc Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof
CN115569123B (zh) * 2022-12-08 2023-03-14 则正(济南)生物科技有限公司 一种富马酸伏诺拉生片剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
JP2906528B2 (ja) * 1990-02-14 1999-06-21 大正製薬株式会社 吸収を促進した内服用固形製剤
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
UA41946C2 (uk) * 1994-07-08 2001-10-15 Астра Актієболаг Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
ZA987800B (en) * 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
ATE252892T1 (de) * 1997-09-11 2003-11-15 Nycomed Danmark Aps Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
DK1109534T3 (da) * 1998-09-10 2003-06-10 Nycomed Danmark As Farmaceutiske præparater med quick release af den aktive substans
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
ES2236011T3 (es) * 1999-12-08 2005-07-16 Pharmacia Corporation Formas cristalinas polimorficas de celecoxib.
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US20040258748A1 (en) * 2001-09-25 2004-12-23 Ashish Madan Process for the preparation of fast dissolving dosage form
IL165383A0 (en) * 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
EP1605916A4 (en) * 2003-02-12 2012-02-22 R & P Korea Co Ltd SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
ES2450648T3 (es) * 2004-06-29 2014-03-25 Takeda Pharma A/S Fabricación de composiciones farmacéuticas con liberación rápida de fármacos insolubles en agua y composiciones farmacéuticas obtenidas mediante el procedimiento de la invención

Also Published As

Publication number Publication date
AU2005256321A1 (en) 2006-01-05
JP2011213730A (ja) 2011-10-27
MXPA06015131A (es) 2007-03-26
EA200971133A1 (ru) 2010-10-29
UA93353C2 (ru) 2011-02-10
SA05260191B1 (ar) 2009-09-02
AU2005256321B2 (en) 2008-11-20
CA2572359C (en) 2010-08-03
CN101513391A (zh) 2009-08-26
KR20070032035A (ko) 2007-03-20
KR100875299B1 (ko) 2008-12-23
EA200700078A1 (ru) 2007-06-29
IL180071A0 (en) 2007-05-15
JP5438898B2 (ja) 2014-03-12
TWI376242B (en) 2012-11-11
US20130059842A1 (en) 2013-03-07
WO2006000228A3 (en) 2006-08-31
NZ552208A (en) 2008-11-28
TNSN06434A1 (en) 2008-02-22
EP1916994A2 (en) 2008-05-07
BRPI0508063A (pt) 2007-07-17
ES2450648T3 (es) 2014-03-25
PL1916994T3 (pl) 2014-05-30
WO2006000228B1 (en) 2006-11-09
EA014443B1 (ru) 2010-12-30
ZA200700531B (en) 2009-09-30
WO2006000228A2 (en) 2006-01-05
CN1976678B (zh) 2010-06-02
EP1916994B1 (en) 2013-12-11
SA108290833B1 (ar) 2012-03-24
MA28754B1 (fr) 2007-07-02
US20070218128A1 (en) 2007-09-20
GEP20094671B (en) 2009-04-27
TW200605919A (en) 2006-02-16
CN101513391B (zh) 2013-03-13
CN1976678A (zh) 2007-06-06
CA2572359A1 (en) 2006-01-05
JP2008504307A (ja) 2008-02-14

Similar Documents

Publication Publication Date Title
NO20065763L (no) Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
DOP2017000280A (es) Formas administración sólidas de palbociclib
ATE528989T1 (de) Kristalline feste rasagilin-base
CY1115660T1 (el) Επιστρωμενες me υμενα και/ή κοκκωμενες ασβεστουχες ενωσεις και η χρηση τους σε φαρμακευτικες συνθεσεις
MA41265B1 (fr) Compositions pour administration de médicaments iléo-jéjunal.
NO20092609L (no) Tannate salt of rasagiline
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
CY1110221T1 (el) Σταθερα φαρμακευτικα σκευασματα νατριουχου μοντελουκαστης
DE602006008625D1 (de) Polymermicellen für die arzneistoffzufuhr
NO20092102L (no) Krystallinformer av aliskiren hemifumarat
BRPI0710508B8 (pt) composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
RS54711B1 (en) PARENTERAL TAPENTADOL ADMINISTRATION
CY1112980T1 (el) Φαρμακευτικες συνθεσεις, οι οποιες διαθετουν βελτιωμενα προφιλ διαλυσης για δυσδιαλυτες δραστικες ουσιες
EP3694331A4 (en) INDAZOLYL-SPIRO [2,3] HEXANCARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
DK1742927T3 (da) Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf
BRPI0516464B8 (pt) método para a preparação de um produto farmacêutico
WO2009028598A1 (ja) 徐放性製剤及びその製造方法
HK1120417A1 (en) Stable nanoparticle formulations
EA202090978A1 (ru) Новые макроциклические производные, способ их получения и содержащие их фармацевтические композиции
PH12017500536A1 (en) Solid pharmaceutical composition comprising amlodipine and losartan
EP3873471A4 (en) N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES
WO2008135852A3 (en) Pharmaceutical compositions comprising nanoparticles and casein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application